Seizure	seizure	O	DISEASE	OTHERS	I
after	after	O	O	O	O
flumazenil	flumazenil	CHEMICALS	O	OTHERS	I
administration	administration	O	O	O	O
in	in	O	O	O	O
a	a	O	O	O	O
pediatric	pediatric	O	O	O	O
patient	patient	O	O	O	O
.	.	O	O	O	O

Flumazenil	flumazenil	CHEMICALS	O	OTHERS	I
is	is	O	O	O	O
a	a	O	O	O	O
benzodiazepine	benzodiazepine	CHEMICALS	O	OTHERS	I
receptor	receptor	O	O	O	O
antagonist	antagonist	O	O	O	O
used	used	O	O	O	O
to	to	O	O	O	O
reverse	reverse	O	O	O	O
sedation	sedation	O	O	O	O
and	and	O	O	O	O
respiratory	respiratory	O	DISEASE	OTHERS	I
depression	depression	O	DISEASE	OTHERS	I
induced	induced	O	O	O	O
by	by	O	O	O	O
benzodiazepines	benzodiazepines	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Seizures	seizures	O	DISEASE	OTHERS	I
and	and	O	O	O	O
cardiac	cardiac	O	DISEASE	OTHERS	I
arrhythmias	arrhythmias	O	DISEASE	OTHERS	I
have	have	O	O	O	O
complicated	complicated	O	O	O	O
its	its	O	O	O	O
use	use	O	O	O	O
in	in	O	O	O	O
adult	adult	O	O	O	O
patients	patients	O	O	O	O
.	.	O	O	O	O

Overdose	overdose	O	DISEASE	OTHERS	I
patients	patients	O	O	O	O
who	who	O	O	O	O
have	have	O	O	O	O
coingested	coingested	O	O	O	O
tricyclic	tricyclic	O	O	O	O
antidepressants	antidepressants	CHEMICALS	O	OTHERS	I
have	have	O	O	O	O
a	a	O	O	O	O
higher	higher	O	O	O	O
risk	risk	O	O	O	O
of	of	O	O	O	O
these	these	O	O	O	O
complications	complications	O	O	O	O
.	.	O	O	O	O

Little	little	O	O	O	O
information	information	O	O	O	O
exists	exists	O	O	O	O
concerning	concerning	O	O	O	O
adverse	adverse	O	O	O	O
effects	effects	O	O	O	O
of	of	O	O	O	O
flumazenil	flumazenil	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
children	children	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
report	report	O	O	O	O
the	the	O	O	O	O
occurrence	occurrence	O	O	O	O
of	of	O	O	O	O
a	a	O	O	O	O
generalized	generalized	O	O	O	O
tonic-clonic	tonic-clonic	O	O	O	O
seizure	seizure	O	DISEASE	OTHERS	I
in	in	O	O	O	O
a	a	O	O	O	O
pediatric	pediatric	O	O	O	O
patient	patient	O	O	O	O
following	following	O	O	O	O
the	the	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
flumazenil	flumazenil	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

